Linfavenix

contains Aesculus hippocastanum, Hamamelis virginiana, Vaccinium myrtillus, ruscus, Pyrus, sorbus, fagaceae and nuts; used for treatment of chronic venous insufficiency and microangiopath

Networked: 1 relevant articles (1 outcomes, 1 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1.	Belcaro, G: 1 article (10/2008)
2.	Cacchio, M: 1 article (10/2008)
3.	Cesarone, M R: 1 article (10/2008)
4.	Dugall, M: 1 article (10/2008)
5.	Fano, F: 1 article (10/2008)
6.	Gizzi, G: 1 article (10/2008)
7.	Grossi, M G: 1 article (10/2008)
8.	Ippolito, E: 1 article (10/2008)
9.	Ledda, A: 1 article (10/2008)
10.	Pellegrini, L: 1 article (10/2008)

Related Diseases

1.	Venous Insufficiency 10/01/2008 - "The aim of this independent study was to demonstrate the rapidity of the efficacy of an oral venotropic compound (Linfavenix, including natural elements) in patients with chronic venous insufficiency (CVI). " 10/01/2008 - "Two groups of patients with chronic venous insufficiency (CVI) ankle swelling) were treated with Linfavenix or with below-knee elastic compression. " 10/01/2008 - "LINFAVENIX: improvement of signs and symptoms of chronic venous insufficiency and microangiopathy."
2.	Edema (Dropsy) 10/01/2008 - "In conclusion venous microangiopathy and edema were improved by the treatment with Linfavenix (better in comparison with compression) in a few days." 10/01/2008 - "A significant level of improvement was reached with Linfavenix, in most patients (10/14) at 2 weeks for RF, at 7 days for the RAS and also at 2 weeks in almost all patients (13/14) considering ASLS and edema. " 10/01/2008 - "The decrease in edema was relevant in both groups at 2 (p<0.05) and 4 weeks (p<0.05) with a minimal but significant difference (p<0.05) between the Linfavenix and the elastic compression group. " 10/01/2008 - "Also the differences observed in ASLS were significant in both groups with an important, significant difference in favour of Linfavenix at 4 weeks (op<0.05) visibile as edema reduction. "